Cargando…
Semi-allogeneic vaccine for T-cell lymphoma
BACKGROUND: Experimental results from studies with inbred mice and their syngeneic tumors indicated that the inoculation of semi-allogeneic cell hybrids (derived from the fusion between syngeneic tumor cells and an allogeneic cell line) protects the animal host from a subsequent lethal challenge wit...
Autores principales: | Yu, Jin, Kindy, Mark S, Gattoni-Celli, Sebastiano |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971246/ https://www.ncbi.nlm.nih.gov/pubmed/17686178 http://dx.doi.org/10.1186/1479-5876-5-39 |
Ejemplares similares
-
Semi-allogeneic vaccines and tumor-induced immune tolerance
por: Yu, Jin, et al.
Publicado: (2009) -
Restoration of Immune Responsiveness to Glioma by Vaccination of Mice with Established Brain Gliomas with a Semi-Allogeneic Vaccine
por: Gattoni-Celli, Sebastiano, et al.
Publicado: (2016) -
A therapeutic cancer vaccine against GL261 murine glioma
por: Kindy, Mark S., et al.
Publicado: (2016) -
Vitamin D binding protein polymorphisms significantly impact vitamin D status in children
por: Newton, Danforth A., et al.
Publicado: (2019) -
Cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV p17 GAG:77–85 epitopes in HIV-infected and uninfected individuals
por: Acierno, Paula M, et al.
Publicado: (2003)